Moog
MOG-A NYSE Aerospace & Defense Financials FY2016βFY2025
Moog's revenue rose 7.0% to $3.9 billion in fiscal 2025. Its operating margin was 11.7%, up from 11.2% a year earlier. Free cash flow was $128 million, up 179.8%. It paid out $179 million in dividends and buybacks, 140% of free cash flow. The diluted share count fell 0.9%.
What Moog does
No business description yet.
- Legal name
- MOOG Inc.
- Fiscal year ends
- September 27, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-25-054103
0000067887
Revenue and margins
Moog had $3.9B of revenue in fiscal 2025, up 7.0% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 8.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $128M in fiscal 2025, 3.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Moog returned $179M to shareholders in fiscal 2025, 140% of free cash flow. The diluted share count fell 0.9%.
Value Moog yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.0B and divides by 32.1M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 29.0x Β· peers 39.5x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Moog can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $99.6M | $102M | $69.0M | $61.7M | $62.0M |
| Debt incl. finance leases | $910M | $865M | $940M | $985M | $1.1B |
| Net debt / EBITDA | 2.2x | 2.1x | 2.0x | 1.8x | 1.8x |
| Debt / equity | 0.7x | 0.6x | 0.6x | 0.5x | 0.5x |
| Interest coverage | 8.0x | 7.7x | 5.8x | 6.1x | 6.2x |
| Current ratio | 2.0x | 2.1x | 2.0x | 2.1x | 2.1x |
| Quick ratio | 1.3x | 1.4x | 1.3x | 1.2x | 1.3x |
| Total assets | $3.4B | $3.4B | $3.8B | $4.1B | $4.4B |
| Total liabilities | $2.0B | $2.0B | $2.2B | $2.2B | $2.4B |
| Shareholders' equity | $1.4B | $1.4B | $1.6B | $1.8B | $2.0B |
| Net debt (β = net cash) | $811M | $763M | $871M | $923M | $1.0B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$5.7M
5 insiders
Of sales under plans
22%
$1.2M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | John ScannellDirector | Sold plan | 3,000 | $413.43 | $1.2M | Form 4 |
| Jun 10, 2026 | Janet M. ColettiDirector | Sold | 604 | $379.66 | $0.2M | Form 4 |
| Jun 9, 2026 | John ScannellDirector | Sold | 3,000 | $373.58 | $1.1M | Form 4 |
| Mar 12, 2026 | Brenda ReichelderferDirector | Sold | 2,000 | $312.27 | $0.6M | Form 4 |
| Feb 5, 2026 | Paul WilkinsonVice President | Sold | 992 | $329.80 | $0.3M | Form 4 |
| Dec 5, 2025 | Donald R FishbackDirector | Sold | 253 | $220.00 | $0.1M | Form 4 |
| Dec 3, 2025 | John ScannellDirector | Sold | 9,000 | $231.73 | $2.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 7 / 9 | 6 / 9 | 7 / 9 |
| Accruals ratio | 1.0% | 0.3% | β0.9% |
| Altman Z'' | 5.22 | 5.41 | 5.48 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Moog MOG-A | $11.0B | 7.0% | 11.7% | 3.3% | 11.7% | 29.0x | 7 | |
| Curtiss-Wright CW | $17.2B | 12.1% | 18.1% | 15.8% | 15.9% | 32.0x | 8 | Compare β |
| ATI ATI | $21.7B | 5.2% | 14.0% | 7.3% | 16.7% | 46.0x | 9 | Compare β |
| BWX Technologies BWXT | $11.7B | 18.3% | 12.7% | 9.2% | 13.9% | 33.0x | 7 | Compare β |
| Axon Enterprise AXON | $34.7B | 33.5% | β2.2% | 2.7% | β2.2% | 174.4x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $2.4B | $2.5B | $2.7B | $2.9B | $2.9B | $2.9B | $3.0B | $3.3B | $3.6B | $3.9B |
| Gross profit | $712M | $734M | $774M | $816M | $744M | $776M | $821M | $898M | $1.0B | $1.1B |
| Research and development | $147M | $144M | $130M | $127M | $111M | $126M | $110M | $107M | $113M | $93.7M |
| Operating income | $238M | $259M | $262M | $321M | $216M | $271M | $283M | $344M | $405M | $450M |
| Interest expense | $34.6M | $34.6M | $36.2M | $39.3M | $38.9M | $33.9M | $36.8M | $59.8M | $66.3M | $72.1M |
| Pretax income | $173M | $182M | $182M | $227M | $5.4M | $204M | $203M | $222M | $270M | $313M |
| Income tax | $49.2M | $41.3M | $86.8M | $52.4M | β$3.8M | $46.6M | $47.8M | $46.4M | $61.0M | $77.6M |
| Net income | $127M | $141M | $95.2M | $175M | $9.2M | $157M | $155M | $175M | $209M | $235M |
| Diluted EPS | $3.47 | $3.90 | $2.64 | $4.96 | $0.28 | $4.87 | $4.83 | $5.47 | $6.45 | $7.33 |
| Diluted shares | 0.04B | 0.04B | 0.04B | 0.04B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | $216M | $218M | $102M | $181M | $279M | $293M | $247M | $140M | $198M | $273M |
| Capital expenditure | $67.2M | $75.8M | $94.5M | $118M | $88.3M | $129M | $139M | $177M | $152M | $145M |
| Free cash flow | $149M | $142M | $7.9M | $63.0M | $191M | $164M | $107M | β$37.7M | $45.9M | $128M |
| Depreciation and amortization | $98.7M | $90.2M | $88.6M | $85.3M | $87.0M | $90.2M | $88.4M | $89.3M | $96.0M | $104M |
| Stock-based compensation | $3.3M | $4.6M | $5.8M | $6.5M | $5.7M | $7.5M | $8.9M | $10.6M | $15.0M | $16.7M |
| Acquisitions | $11.0M | $40.5M | $48.4M | $0.0M | $54.3M | $77.6M | $11.8M | $0.0M | $5.9M | $41.2M |
| Share buybacks | $44.9M | $8.6M | $8.2M | $41.0M | $232M | $31.7M | $48.6M | $29.3M | $36.7M | $143M |
| Dividends paid | $0.0M | $0.0M | $17.9M | $34.9M | $25.2M | $32.1M | $33.0M | $34.1M | $35.5M | $36.4M |
| Dividends and buybacks | $44.9M | $8.6M | $26.1M | $75.8M | $258M | $63.8M | $81.5M | $63.4M | $72.2M | $179M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $325M | $368M | $126M | $89.7M | $84.6M | $99.6M | $102M | $69.0M | $61.7M | $62.0M |
| Total debt | $1.0B | $961M | $865M | $833M | $939M | $910M | $838M | $863M | $874M | $946M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $13.6M | $17.9M | $26.8M | $76.8M | $110M | $134M |
| Current assets | $1.5B | $1.6B | $1.5B | $1.6B | $1.6B | $1.7B | $1.8B | $1.9B | $2.1B | $2.4B |
| Current liabilities | $589M | $629M | $681M | $728M | $711M | $869M | $838M | $958M | $1.0B | $1.1B |
| Inventory | $479M | $489M | $513M | $535M | $623M | $613M | $589M | $719M | $863M | $914M |
| Property and equipment, net | $522M | $523M | $553M | $587M | $601M | $646M | $689M | $826M | $929M | $1.0B |
| Total assets | $3.0B | $3.1B | $3.0B | $3.1B | $3.2B | $3.4B | $3.4B | $3.8B | $4.1B | $4.4B |
| Total liabilities | $2.0B | $1.9B | $1.7B | $1.8B | $2.0B | $2.0B | $2.0B | $2.2B | $2.2B | $2.4B |
| Shareholders' equity | $988M | $1.2B | $1.2B | $1.3B | $1.2B | $1.4B | $1.4B | $1.6B | $1.8B | $2.0B |
| Margins | ||||||||||
| Gross margin | 29.5% | 29.4% | 28.6% | 28.1% | 25.8% | 27.2% | 27.0% | 27.1% | 28.1% | 27.4% |
| Operating margin | 9.9% | 10.4% | 9.7% | 11.1% | 7.5% | 9.5% | 9.3% | 10.4% | 11.2% | 11.7% |
| EBITDA margin | 14.0% | 14.0% | 13.0% | 14.0% | 10.5% | 12.7% | 12.2% | 13.1% | 13.9% | 14.3% |
| Net margin | 5.3% | 5.7% | 3.5% | 6.0% | 0.3% | 5.5% | 5.1% | 5.3% | 5.8% | 6.1% |
| FCF margin | 6.2% | 5.7% | 0.3% | 2.2% | 6.6% | 5.8% | 3.5% | β1.1% | 1.3% | 3.3% |
| Returns | ||||||||||
| Return on capital | 9.9% | 11.5% | 7.3% | 12.3% | 10.4% | 9.7% | 9.8% | 11.6% | 12.0% | 11.7% |
| Return on capital employed | 9.8% | 10.6% | 11.1% | 13.8% | 8.8% | 10.7% | 11.0% | 12.7% | 13.8% | 14.1% |
| Return on equity | 12.8% | 12.8% | 7.8% | 13.7% | 0.7% | 11.9% | 10.9% | 11.5% | 12.2% | 12.3% |
| Return on assets | 4.2% | 4.6% | 3.2% | 5.7% | 0.3% | 4.7% | 4.5% | 4.9% | 5.3% | 5.5% |
| Growth | ||||||||||
| Revenue growth | β4.5% | 3.6% | 8.5% | 7.2% | β0.7% | β1.1% | 6.4% | 9.2% | 8.8% | 7.0% |
| Net income growth | β3.9% | 11.5% | β32.6% | 83.3% | β94.7% | 1,608.0% | β1.3% | 12.9% | 19.2% | 12.6% |
| EPS growth | 3.6% | 12.4% | β32.3% | 87.9% | β94.4% | 1,639.3% | β0.8% | 13.3% | 17.9% | 13.6% |
| FCF growth | β41.4% | β4.5% | β94.4% | 698.5% | 203.0% | β13.8% | β34.7% | β135.1% | β | 179.8% |
| Share count change | β7.1% | β0.8% | β0.5% | β2.4% | β5.0% | β3.4% | β0.6% | β0.2% | 1.0% | β0.9% |
| Financial health | ||||||||||
| Net debt / EBITDA | 2.0x | 1.7x | 2.1x | 1.8x | 2.8x | 2.2x | 2.1x | 2.0x | 1.8x | 1.8x |
| Debt / equity | 1.0x | 0.8x | 0.7x | 0.6x | 0.8x | 0.7x | 0.6x | 0.6x | 0.5x | 0.5x |
| Interest coverage | 6.9x | 7.5x | 7.2x | 8.2x | 5.6x | 8.0x | 7.7x | 5.8x | 6.1x | 6.2x |
| Current ratio | 2.6x | 2.6x | 2.2x | 2.2x | 2.3x | 2.0x | 2.1x | 2.0x | 2.1x | 2.1x |
| Quick ratio | 1.8x | 1.8x | 1.4x | 1.5x | 1.4x | 1.3x | 1.4x | 1.3x | 1.2x | 1.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.8% | 3.0% | 3.5% | 4.1% | 3.1% | 4.5% | 4.6% | 5.4% | 4.2% | 3.8% |
| Stock comp / revenue | 0.1% | 0.2% | 0.2% | 0.2% | 0.2% | 0.3% | 0.3% | 0.3% | 0.4% | 0.4% |
| Payouts / FCF | 30.2% | 6.1% | 330.9% | 120.3% | 134.9% | 38.8% | 75.9% | β | 157.4% | 139.6% |
| Quality scores | ||||||||||
| Piotroski F-score | 8.0 | 7.0 | 6.0 | 8.0 | 5.0 | 7.0 | 7.0 | 7.0 | 6.0 | 7.0 |
| Altman Z'' | 5.0 | 5.3 | 5.3 | 5.6 | 5.1 | 5.0 | 5.3 | 5.2 | 5.4 | 5.5 |
| Accruals ratio | β3.0% | β2.5% | β0.2% | β0.2% | β8.5% | β4.1% | β2.7% | 1.0% | 0.3% | β0.9% |
Source: SEC EDGAR XBRL filings (CIK 0000067887). Data updated October 12, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.